experimental diabetes cardiovascular tissues during early stages of Upregulation of PKC genes and isozymes in

[1]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[2]  P. Arner.  Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.

[3]  A. Goldfine,et al.  Inhibition of Protein Kinase C&bgr; Prevents Impaired Endothelium-Dependent Vasodilation Caused by Hyperglycemia in Humans , 2002, Circulation research.

[4]  D. Gutterman.  Vascular dysfunction in hyperglycemia: is protein kinase C the culprit? , 2002, Circulation research.

[5]  G. King,et al.  Protein kinase C and the development of diabetic vascular complications , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[6]  A. Newton,et al.  Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. , 2001, Chemical reviews.

[7]  I. Idris,et al.  Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes , 2001, Diabetologia.

[8]  H. Nawata,et al.  Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells , 2001, Diabetologia.

[9]  A. Fields,et al.  Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. , 2001, Cancer research.

[10]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[11]  P A Insel,et al.  Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[12]  J. P. Walsh,et al.  Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis , 2000, Diabetologia.

[13]  S. Yuan,et al.  Protein Kinase C Activation Contributes to Microvascular Barrier Dysfunction in the Heart at Early Stages of Diabetes , 2000, Circulation research.

[14]  M. Meier,et al.  Protein kinase C activation and its pharmacological inhibition in vascular disease , 2000, Vascular medicine.

[15]  E. Ustinova,et al.  Ammonium Chloride Potentiation of Streptozotocin-Induced Diabetes in Juvenile Pigs , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[16]  G. King,et al.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  I. West.  Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[18]  F. Luft,et al.  Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. , 1999, Kidney international.

[19]  N. Dhalla,et al.  Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.

[20]  M. Kazanietz,et al.  New insights into the regulation of protein kinase C and novel phorbol ester receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  G. King,et al.  Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. , 1999, Circulation.

[22]  P. Simpson.  β-Protein Kinase C and Hypertrophic Signaling in Human Heart Failure , 1999 .

[23]  G. King,et al.  In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. , 1998, The Journal of clinical investigation.

[24]  P. Buttrick,et al.  Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. , 1997, Circulation research.

[25]  S. Bursell,et al.  Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. , 1997, Investigative ophthalmology & visual science.

[26]  G. Fishman,et al.  Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.

[27]  R. Dietz,et al.  High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. , 1997, Circulation research.

[28]  G. King,et al.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. King,et al.  Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. , 1997, The Journal of clinical investigation.

[30]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[31]  S. Bursell,et al.  Normalization of Diacylglycerol-Protein Kinase C Activation by Vitamin E in Aorta of Diabetic Rats and Cultured Rat Smooth Muscle Cells Exposed to Elevated Glucose Levels , 1994, Diabetes.

[32]  G. King,et al.  Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. , 1994, The American journal of physiology.

[33]  G. King,et al.  Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.

[34]  F. DeRubertis,et al.  Activation of Protein Kinase C in Glomerular Cells in Diabetes: Mechanisms and Potential Links to the Pathogenesis of Diabetic Glomerulopathy , 1994, Diabetes.

[35]  S. Bursell,et al.  Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. , 1993, The American journal of physiology.

[36]  G. King,et al.  Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. McNeill,et al.  Protein kinase C activity is altered in diabetic rat hearts. , 1992, Biochemical and biophysical research communications.

[38]  Y. Nishizuka,et al.  Expression and properties of two types of protein kinase C: alternative splicing from a single gene. , 1987, Science.

[39]  D. Mochly‐Rosen,et al.  Anchoring proteins for protein kinase C: a means for isozyme selectivity. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  M. Given,et al.  Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. , 1998, American journal of physiology. Heart and circulatory physiology.

[41]  S. Steinberg,et al.  Protein kinase C isoform diversity in the heart. , 1995, Journal of molecular and cellular cardiology.

[42]  B. Wolf,et al.  Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. , 1991, The Journal of clinical investigation.

[43]  M. Brownlee.  Insight Review Articles , 2022 .